Key result
A 23-year-old pregnant woman with a mechanical mitral valve was successfully managed for secondary postpartum hemorrhage using fresh frozen plasma and bridging anticoagulation therapy.
Why the study?
Managing anticoagulation in pregnant women with artificial heart valves is challenging due to the competing risks of thromboembolism and postpartum haemorrhage.
Case Report (n=1)
No
Managing anticoagulation in pregnant women with mechanical heart valves requires a multidisciplinary approach due to the high risk of hemorrhagic complications such as postpartum hemorrhage.
Answers are grounded in this paper and cite their sources.
Case highlights peripartum anticoagulation risks in RHD; leaves optimal postpartum strategies open.
A pregnant woman with rheumatic heart disease always runs the risk of developing both thromboembolic and hemorrhagic symptoms, necessitating careful monitoring of her anticoagulation treatments both throughout pregnancy and after delivery. Postpartum haemorrhage, a hemorrhagic manifestation, can be challenging to control and presents a significant challenge when it comes to beginning anticoagulation after delivery. Thus, pregnancy in these patients is an extremely risky endeavour. Given that these women take anticoagulants, managing these women with artificial heart valves throughout pregnancy can be difficult. The diminished clotting ability in these women may be the cause of postpartum haemorrhage, and a multidisciplinary approach is necessary for a successful treatment. To manage this potentially fatal illness, a well-equipped institution with proper support systems is essential. We present a 23-year-old primigravida who was 39 weeks and three days pregnant and had a repaired aortic valve as well as a prosthetic mitral valve. She was taking warfarin to prevent clotting when she was pregnant.
No takes yet. Share an insight, caveat, or question.
Thakur et al. (2023) conducted a case report in Secondary postpartum hemorrhage in pregnancy with mechanical mitral valve (n=1). Anticoagulation management (Warfarin, LMWH, UFH) was evaluated on Management of secondary postpartum hemorrhage. A 23-year-old pregnant woman with a mechanical mitral valve was successfully managed for secondary postpartum hemorrhage using fresh frozen plasma and bridging anticoagulation therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: